• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750TFX26A
Device Problem Material Deformation (2976)
Patient Problem Cusp Tear (2656)
Event Date 07/13/2021
Event Type  Injury  
Manufacturer Narrative
Investigation is ongoing.
 
Event Description
As reported, during a transfemoral transcatheter aortic valve replacement (tavr) with a 26 mm sapien 3, after valve deployment there was mild aortic insufficiency.The physician re-wired and ballooned the area causing damage to the tavr valve and to the mitral leaflet.The patient was emergently opened for repair.The patient is stable post procedure.
 
Manufacturer Narrative
The device was not returned to edwards lifesciences for evaluation.In addition, no applicable imagery was provided for review.A device history review (dhr) was performed and did not reveal any manufacturing nonconformance that would have contributed to this complaint event.A lot history review was performed and revealed no additional similar complaints relating to frame damaged during use.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.As no device was returned and there is no evidence to support a manufacturing/design defect potentially contributed to the complaint, therefore a manufacturing mitigation review was not performed.The frame damage reported in this event is likely a consequence of an incorrect wire placement for a non-ew bav device.In this case, the wire was not inserted through the valve, but through the side of the valve.As the bav was inflated, the balloon compressed the frame and aorta wall causing damage to the valve and to the mitral leaflet.Edwards risk management does not conduct risk assessments for events associated with non-ew devices.As such, the review of the risk management file is complete, and no further action is required at this time.The complaint for frame damage was unable to be confirmed due to no device/relevant imagery provided for evaluation.However, review of the dhr, and lot history provided no indication that manufacturing nonconformance was a contributing factor.A review of ifu/training materials also revealed no deficiencies.As reported, ''during tf tavr with a 26mm s3, after valve deployment there was mild ai, the physician re wired what he thought was through the tavr valve, there was paravalvular and ballooned the area causing damage to the tavr valve and to the mitral leaflet.The was emergently opened for repair''.In this case, the guidewire was incorrectly placed prior to post-dilation.The wire was not inserted through the valve, but through the side of the valve, and this resulted in incorrect placement of the device.As the bav was inflated, the balloon compressed the frame and aorta wall causing damage to the valve and to the mitral leaflet.As such, available information suggests that procedural factors (user error -incorrect placement of wire) may have contributed to the complaint event.Since no product non-conformances or ifu/training deficiencies were identified during evaluation, a product risk assessment escalation and corrective/preventative actions (capa) are not required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key12291358
MDR Text Key265594948
Report Number2015691-2021-04549
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103201338
UDI-Public(01)00690103201338(17)230422
Combination Product (y/n)N
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Remedial Action Other
Type of Report Initial,Followup
Report Date 10/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/22/2023
Device Model Number9750TFX26A
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/13/2021
Initial Date FDA Received08/06/2021
Supplement Dates Manufacturer Received10/26/2021
Supplement Dates FDA Received10/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-